Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs?

Over the past two years, Merck (NYSE: MRK) has faced several challenges, resulting in a decline in the company's share price. Even worse, the pharmaceutical giant could face more issues ahead, ...
Kalkine Media

Merck (NYSE:MRK) S&P 500 Today Shows Pharma-Sector Growth

Merck & Co., Inc. (NYSE:MRK) drives global therapeutic progress as s&p 500 today themes reflect major healthcare influence.
FierceBiotech

Merck Announces New Phase III Data for Suvorexant, an Investigational Insomnia Medicine

Merck (MRK), known as MSD outside the United States and Canada, today announced new data for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia. The new data ...
Business Wire

In Pivotal Phase III Studies, Merck’s Investigational Medicine Boceprevir Helped Majority of Patients with Chronic Hepatitis C Genotype 1 Infection Achieve Sustained ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been ...

Merck's oral HIV treatment non-inferior to Gilead's Biktarvy in late-stage trial

Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug Biktarvy in a late-stage study involving previously untreated adult ...
BioPharma Dive

Kelun, Merck tout ADC as potential first-line treatment in lung cancer

The partners said a TROP2-targeting antibody drug conjugate succeeded in a late-stage trial, paving the way for potential ...
VentureBeat

Merck tests delivering temperature-controlled medicine via drone

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Drone startup Volansi says it’s partnering with Merck to deliver ...
The Caledonian-Record

Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced plans to present first-in-human data for MK-2214 and MK-1167 at Clinical Trials on Alzheimer’s Disease (CTAD) ...
Nasdaq

Merck and Ridgeback’s Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies

KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced data from six preclinical studies ...
Business Wire

Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in ...

KENILWORTH, N.J. & MIAMI--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that a total of approximately 3.1 million ...
Medical Dialogues

Merck division gets USFDA conditional approval for Exzolt Cattle-CA1 against cattle fever tick

Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., ...
Time

Medicine: What the Doctor Ordered

Though foreign visitors might be surprised to hear it, U.S. drugstores also sell drugs. They sell quite a lot of drugs. More than twelve times every second — almost 400 million times a year — some ...